[1] LIU YP,LV X,ZOU X,et al.Minimally invasive surgery and compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma [J].Cancer,2019,39(1):634-644.
[2] YAO XS,GONG GZ,ZUO GP,et al.Study of the dose-volume parameters variation in tumor target volumes and organs at risk during nasopharyngeal carcinoma radiotherapy applying deformation registration [J].Translational Cancer Research,2019,8(8):2886-2892.
[3] MUHAMMAD,SK,BAREERA M,QUDSIA Y,et al.Molecular docking studies reveals Rhein from rhubarb(Rheum rhabarbarum) as a putative inhibitor of ATP-binding cassette super family G member 2[J].Medicinal Chemistry,2021,17(3):273-288.
[4] EKAPHOP S,CHOMPORN S,SITH P,et al.Correlation of APC,CYP3A4,and ESR2 expressions in locally advanced rectal cancer with the pathologic response of preoperative concurrent CAPOX/RT[J].Drug Metabolism & Disposition,2014,32(15):533-539.
[5] LU S,HE ZF,LIAO ZW,et al.Single nucleotide polymorphisms and mutations of miRNA binding site at BCL11B-3’UTR in healthy individuals and patients with T-ALL[J].Chinese Journal of Pathophysiology,2018,34(07):1228-1231.
[6] YANG R,TAO ZZ,HUANG ML,et al.Knockout of the placenta specific 8 gene radiosensitizes nasopharyngeal carcinoma cells by activating the PI3K/AKT/GSK3β pathway[J].American journal of translational research,2018,10(2):455-464.
[7] TANG LL,GUO R,ZHANG N,et al.Effect of radiotherapy alone vs radiotherapy with concurrent chemoradiotherapy on survival without disease relapse in patients with low-risk nasopharyngeal carcinoma:a randomized clinical trial[J].JAMA,2022,328(8):728-736.
[8]ZHANG SS,WANG BQ,ZHENG LL,et al.Advances in research on microRNAs related to the invasion and metastasis of nasopharyngeal carcinoma[J].Current Molecular Pharmacology,2022,15(3):463-474.
[9]BENZEID R,GIHBID A,TAWFIQ N,et al.Genetic polymorphisms in ERCC1 gene and their association with response to radiotherapy in moroccan patients with nasopharyngeal carcinoma[J].Asian Pacific Journal of Cancer Prevention,2023,24(1):93-99.
[10]WARDANA T,OKTRIANI R,MURJAYANTO CH,et al.MicroRNA gene signature for predicting mechanisms in nasopharyngeal carcinoma:a case study on the potential application of circulating biomarkers[J].Microrna,2023,12(1):29-44.
[11]SHEN B,DONG Y,YING XJ,et al.Expression and significance of ABCG2 and NF-κB p65 in nasopharyngeal carcinoma and its clinical significance [J].Journal of Clinical Oncology,2012,17(5):424-427.
[12]WANG L,LIN N,LI Y,et al.The PI3K/AKT signaling pathway regulates ABCG2 expression and confers resistance to chemotherapy in human multiple myeloma[J].Oncology Reports,2019,41(3):1678-1690.
[13]GUAN GF,ZHANG DJ,ZHENG Y,et al.Abnormal Wnt signaling and overexpression of ABCG2 contributes to drug efflux properties of side population cells in nasopharyngeal carcinoma[J].Molecular Medicine Reports,2015,12(3):4352-4357.
[14]HUANG RK,DU RC,XIONG QB,et al.Expression and clinical significance of Skp2 and ABCG2 in human nasopharyngeal carcinoma tissues[J].Chinese Journal of Cancer Prevention and Treatment,2015,22(15):1184-1188.
[15]YU LL,HU BW,HUANG HX,et al.A two-stage genome-wide association study identifies novel germline genetic variations in CACNA2D3 associated with radiotherapy response in nasopharyngeal carcinoma[J].Journal of Translational Medicine,2023,21(1):11.
[16]ZHANG WH,DAI EN,HE YX,et al.Association of single nucleotide polymorphisms of MTHFR C677T and ABCG2 G34A with progression-free survival of stage Ⅳ colon adenocarcinoma [J].Modern Digestion & Intervention,2019,8(120):227-233.
[17]AKIMITSU M,HITOSHI A,KEI I,et al.Effects of ABCB1 and ABCG2 polymorphisms on the pharmacokinetics of abemaciclib[J].European Journal of Clinical Pharmacology,2022,78(8):1239-1247.
[18]DAI ZM,KANG HF,ZHANG WG,et al.The associations of single nucleotide polymorphisms in miR196a2,miR-499,and miR-608 with breast cancer susceptibility:A STROBE-compliant observational study[J].Medicine(Baltimore),2016,95(7):e2826.
[19]WANG LL,CHOU YF,CHEN PR,et al.Differential miRNA expression in repeated recurrence of nasopharyngeal carcinoma[J].Cancer Letter,2014,344(2):188-194.
[20]TAN LP,TAN GW,VIJAYA MS,et al.Systematic comparison of plasma EBV DNA,anti-EBV antibodies and miRNA levels for early detection and prognosis of nasopharyngeal carcinoma[J].International Journal of Cancer,2020,146(8):2336-2347.
[21]QIU FM,YANG L,ZhANG LS,et al.Polymorphism in mature microRNA-608 sequence is associated with an increased risk of nasopharyngeal carcinoma[J].Gene,2015,565(2):180-186.
[22]ZHENG J,DENG JQ,XIAO M,et al.A sequence polymorphism in miR-608 predicts recurrence after radiotherapy for nasopharyngeal carcinoma[J].Cancer Research,2013,73(16):5151-5162.
[23]WU Y,WEI XY,YUAN ZL,et al.Phase II study of induction chemotherapy followed by concurrent chemoradiotherapy with raltitrexed and Cisplatin in locally advanced nasopharyngeal carcinoma[J].Chinese Journal of Cancer Research,2020,32(5):665-672.
[24]NABIL T,SANA E,IIHEM C,et al.Prognostic factors in metastatic nasopharyngeal carcinoma[J].Brazilian Journal of Otorhinolaryngology,2022,88(2):212-219.